Pharmaceutical Executive
More signs of alignment between startups, pharma, and payers.
Leo Grimaldi, MD
Advertisement
Articles by Leo Grimaldi, MD
Pharmaceutical Executive
Pharma companies are increasingly turning to tech enabled behavioral-based interventions to help improve patient outcomes through their diagnosis, treatment, and coordination of care.
Advertisement
Latest Updated Articles
The Shrinking Disconnect in Digital TherapeuticsAugust 1st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5